SCHEMBL5205679

SCHEMBL5205679

CC(C)n1c(NCCCNS(C)(=O)=O)nc(OCc2ccc(F)cc2F)c(Br)c1=O

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 2/20 0.44
MAPK14 Q16539 18/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5202773 0.95 MAPK8 (0.42) MAPK8MAPK14
SCHEMBL5206869 0.88 MAPK14 (0.42) MAPK14
SCHEMBL5204040 0.86 MAPK14 (0.45) MAPK14
SCHEMBL5204566 0.85 MAPK14 (0.46) MAPK14
SCHEMBL5203950 0.85 MAPK14 (0.44) MAPK14
SCHEMBL5204251 0.85 MAPK14 (0.41) MAPK8MAPK14
SCHEMBL5206712 0.84 MAPK8 (0.42) MAPK8MAPK14
SCHEMBL5207204 0.84 MAPK14 (0.40) MAPK14
SCHEMBL5209554 0.84 MAPK14 (0.42) MAPK14
SCHEMBL5206968 0.83 MAPK14 (0.43) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1802590-A1 SUBSTITUTED N-ALKYLPYRIMIDINONES Pharmacia & Upjohn Company LLC (US) 2007-07-04 EP claimed
WO-2006040666-A1 SUBSTITUTED N-ALKYLPYRIMIDINONES PHARMACIA & UPJOHN COMPANY LLC (US) 2006-04-20 WO claimed
EP-1802590-A1 SUBSTITUTED N-ALKYLPYRIMIDINONES Pharmacia & Upjohn Company LLC (US) 2007-07-04 EP disclosed
WO-2006040666-A1 SUBSTITUTED N-ALKYLPYRIMIDINONES PHARMACIA & UPJOHN COMPANY LLC (US) 2006-04-20 WO disclosed